Chemed Corporation Profile Avatar - Palmy Investing

Chemed Corporation

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segment…

Medical - Care Facilities
US, Cincinnati [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
29.88 29.25 28.43 27.74 28.62 28.95 29.53 29.26 30.97 31.08 31.85 33.73 35.98 35.84 32.59
Profit Margin
6.20 6.39 6.34 6.24 5.46 6.82 7.14 6.90 5.89 11.53 11.34 15.36 12.55 11.69 12.03
Operating Margin
10.62 11.21 11.34 10.94 9.44 11.56 11.95 11.34 6.78 13.67 13.28 18.74 16.04 16.09 15.14
EPS Growth
6.82 10.03 15.75 12.65 -10.17 36.56 12.95 1.53 -7.98 109.49 7.58 45.39 -14.39 -2.45 8.31
Return on Assets (ROA)
9.00 9.86 10.80 10.39 8.64 11.55 12.94 12.36 10.67 21.07 17.34 22.26 20.00 17.31 15.48
Return on Equity (ROE)
15.46 17.71 20.78 19.70 17.20 22.00 21.49 20.75 18.17 34.76 30.27 35.45 43.09 31.25 24.60
Return on Invested Capital (ROIC)
12.32 14.13 16.20 15.25 13.15 17.16 18.68 17.35 14.79 30.10 22.96 30.33 27.77 24.87 21.11
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
18.56 19.18 20.96 20.35 20.54 17.15 10.71 12.36 11.00 10.56 17.03 9.44 24.10 17.13 8.81
Debt/Equity
31.88 34.46 40.32 38.58 40.89 32.68 17.78 20.75 18.73 17.42 29.72 15.03 51.91 30.93 14.00
Debt/EBITDA
25.75 63.33 70.24 55.04 50.13 65.16 35.11 43.29 57.19 29.77 67.38 -5.99 70.68 43.94 -26.96
Debt/Capitalization
24.17 25.63 28.73 27.84 29.02 24.63 15.10 17.18 15.77 14.83 22.91 13.06 34.17 23.62 12.28
Interest Debt per Share USD
7.29 7.58 8.80 10.02 10.91 9.07 5.63 6.86 6.57 6.72 13.81 8.63 20.77 16.85 10.51
Debt Growth
-27.50 4.66 4.76 4.86 4.96 -19.65 -38.14 19.18 -6.94 -11.86 142.08 -37.29 138.94 -23.66 -37.20
Liquidity
Current Ratio
145.69 131.78 103.68 126.05 61.72 99.44 88.02 98.88 90.97 83.39 72.71 110.13 76.15 91.73 160.50
Quick Ratio
121.89 109.09 79.78 103.85 48.41 79.03 70.62 85.74 64.47 64.87 57.20 96.80 56.25 71.85 142.76
Cash Ratio
82.61 33.42 26.19 44.34 23.19 8.05 8.60 8.91 5.75 2.52 2.35 54.39 10.88 24.94 84.59
Operating Cash Flow Ratio
100 - - 100 - - - - - - 100 - - - - 100 100 100 100 100 100
Turnover
Inventory Turnover
11,064.22 11,723.81 11,196.17 14,640.42 15,050.10 16,774.85 17,225.37 19,381.95 21,569.78 21,536.27 17,704.72 19,424.91 13,546.92 13,336.03 12,716.32
Receivables Turnover
2,226.36 1,133.24 1,740.12 1,532.19 1,540.08 1,168.70 1,452.44 1,194.42 1,466.53 1,491.71 1,347.84 1,639.36 1,559.04 1,531.45 1,247.54
Payables Turnover
1,602.76 1,622.84 2,012.41 2,131.79 2,415.84 2,208.53 2,489.10 2,817.74 2,378.51 2,449.94 2,585.32 2,541.21 1,875.35 3,270.65 3,158.16
Asset Turnover
145.24 154.25 170.37 166.36 158.14 169.35 181.08 179.18 181.16 182.74 152.84 144.93 159.32 148.05 128.60
Coverage
Interest Coverage
1,089.27 1,200.12 1,106.91 1,062.41 887.22 2,050.14 5,060.58 4,811.55 2,645.95 4,882.40 5,675.41 16,546.92 18,363.92 7,493.37 11,030.57
Asset Coverage
400 300 300 300 300 400 600 600 600 800 400 700 200 400 900
Cash Flow Coverage (CFGR)
105.72 54.02 104.53 75.34 82.18 74.77 187.95 124.50 160.57 278.77 139.51 361.34 95.38 125.46 212.94
EBITDA Coverage
1,300 1,400 1,300 1,300 1,300 2,400 5,900 5,800 3,600 5,600 6,800 19,300 22,000 8,500 12,900
Dividend Coverage
-900 -600 -600 -600 -500 -600 -700 -600 -500 -1,100 -1,100 -1,500 -1,200 -1,100 -1,100
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 200 100 100 100
Market Prospects
Dividend Yield
0.76 0.83 1.19 1.00 1.01 0.79 0.62 0.63 0.45 0.41 0.28 0.25 0.27 0.29 0.27
Earnings Yield
6.85 5.70 8.18 6.88 5.54 5.48 4.36 4.14 2.52 4.52 3.14 3.76 3.24 3.28 3.10
Price/Earnings (P/E)
14.5963 17.5300 12.2237 14.5346 18.0560 18.2630 22.9168 24.1670 39.7463 22.1325 31.8954 26.6000 30.8717 30.5268 32.2943
Price/Book (P/B)
225.70 310.46 254.05 286.35 310.63 401.86 492.37 501.43 722.15 769.31 965.38 942.94 1,330.17 954.06 794.36
Price/Sales (P/S)
90.48 112.02 77.51 90.77 98.66 124.55 163.74 166.66 234.12 255.19 361.84 408.63 387.54 356.92 388.64
Price/Cash Flow (P/CF)
669.63 1,667.79 602.82 985.06 924.39 1,644.76 1,473.54 1,941.01 2,401.41 1,584.32 2,328.49 1,736.76 2,686.54 2,459.04 2,664.40
End of CHE's Analysis
CIK: 19584 CUSIP: 16359R103 ISIN: US16359R1032 LEI: - UEI: -
Secondary Listings
CHE has no secondary listings inside our databases.